Effect of Myofascial Release Therapy Applied to Selective Muscles on Mobility and Function in Patients With Temporomandibular Dysfunction: A Randomized Controlled Trial

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

We aim to compare the effectiveness of MFR and exercise therapy on mobility and function by investigating the effectiveness of the Myofascial Release Technique (MFR), which we will apply to the muscles we choose related to the facial system connection in participants with temporomandibular dysfunction (TMD) and low back pain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Participants aged 18-50 years diagnosed with TMD

• Persons with a score of 20% or more on the Oswestry waist index, and

• People with low back pain for more than 3 months

• Persons with mechanical low back pain and lumbar disc herniation without neurological deficits will be included in the study.

• Persons with acute or chronic temporomandibular dysfunction will be included

Locations
Other Locations
Turkey
Istanbul Medipol University
Istanbul
Time Frame
Start Date: 2022-12-23
Completion Date: 2023-06-24
Participants
Target number of participants: 45
Treatments
Experimental: Working group
A total of 10 sessions will be applied myofascial release technique for 4 weeks, 3 times a week for the first 2 weeks, and 2 times a week for the next 2 weeks. Evaluations will be made at the beginning of the study and at the end of 4 weeks
Experimental: Exercise group
The stretching exercises that we planned to give to the exercise group were planned for the muscles to which we will apply myofascial technique. Evaluations will be made at the beginning of the study and at the end of 4 weeks
Experimental: Control group
No application will be made to the control group. Evaluations will be made at the beginning of the study and at the end of 4 weeks
Sponsors
Leads: Istanbul Medipol University Hospital

This content was sourced from clinicaltrials.gov